ReachMD
CME
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Red Blood Cell Alloimmunization, Pathophysiology, Diagnosis, Treatment, and Prevention 30.09.2022 14:00
Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Kenneth J. Moise Jr., MD This program is no longer available for credit. Program Chairman: Roberto Romero M.D. D.Med Sci. Chief, Perinatology Research Branch Division of Maternal-Fetal Medicine and Obstetrics Division of Intramural Research NICHD/NIH/DHHS Editor-in-Chief for Obstetrics The American Journal of Obstetrics and Gynecology Are you taking th...
Management of ADPKD 23.09.2022 26:00
Guest: Neera Dahl, MD, PhD Guest: Craig E. Gordon, MD This Expert Exchange webcast is designed to help improve clinicians’ ability to apply pharmacologic and non-pharmacologic strategies in the management of patients with ADPKD. This activity is not available for continuing education credit.
Improved Outcomes in mCRPC with PSMA-Directed Diagnostics and Therapies 31.08.2022 56:30
Host: Ayse Tuba Kendi, MD Guest: A. Oliver Sartor, MD Prostate-specific membrane antigen (PSMA) is highly expressed on prostate cancer (PC) cells and can be detected in tumors using positron emission tomography imaging. Even though clinical features predict different stages of PC progression, the application of imaging to guide treatment is still evolving but gaining substantial evidence for the t...
Evolving Perspectives in PIK3CA-related Overgrowth Spectrum Diagnosis & Treatment 26.08.2022 38:00
Host: William Mencia, MD, FACEHP, CHCP Guest: Julie Blatt, MD Guest: Taizo Nakano, MD PIK3CA-related overgrowth spectrum (PROS) refers to various clinical entities that share the same pathogenetic mechanism. These disorders are caused by somatic gain-of-function PIK3CA mutations. Diagnosis of PROS is often challenging and requires DNA sequencing of the affected tissue. PIK3CA genetic mutations var...
HER2-Directed ADCs in Breast Cancer 30.06.2022 5:00
Guest: Sara A. Hurvitz, MD, FACP HER2-Directed ADCs in Breast Cancer
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 4: Emerging Therapies 31.08.2021 27:30
Guest: Arlene B. Chapman, MD Guest: Michel Chonchol, MD This Expert Exchange webcast aims to improve clinicians’ awareness of emerging agents in the treatment of patients with ADPKD.
A Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway 31.08.2021 28:30
Host: Jennifer Caudle, DO Guest: Mikkael A. Sekeres, MD, MS Guest: Sara M. Tinsley, PhD, ARNP, AOCNP Please note: This activity is no longer available for continuing education credit. There is a lack of available therapeutic options for the management of patients with myeloid malignancies, including myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia...
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 3: Management 16.08.2021 28:30
Guest: Michel Chonchol, MD Guest: Frederic Rahbari-Oskoui, MD, MSc This Expert Exchange webcast aims to improve clinicians’ ability to manage patients diagnosed with ADPKD.
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 2: Progression and Prognostication 05.08.2021 23:00
Guest: Matthew B. Lanktree, MD, PhD Guest: Neera Dahl, MD, PhD This Expert Exchange webcast aims to improve clinicians’ ability to properly monitor disease progression and make treatment decisions based on prognostic indicators.
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 1: Detection and Diagnosis 04.08.2021 24:30
Guest: Arlene B. Chapman, MD Guest: Matthew B. Lanktree, MD, PhD This Expert Exchange webcast aims to improve clinicians’ ability to detect and diagnose ADPKD in at-risk patients.
The Clinical Significance of Imaging in the Management of ADPKD 28.06.2021 45:30
Guest: Jimmy T. Lee, MD Guest: Arlene B. Chapman, MD This Expert Exchange webcast aims to better define the importance radiological imaging plays in the management of patients with autosomal dominant polycystic kidney disease (ADPKD).
COVID-19 Vaccines & Considerations for Approval 14.01.2021 12:00
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Mira Irons, MD Guest: Shannon Curtis Following the approval of the first COVID-19 vaccine, mass-vaccination has made approving a vaccine difficult. How are the Food and Drug Administration and the Centers for Disease Control deciding on which vaccinations to authorize? Dr. Mira Irons and Shannon Curtis of the American Medical Association join Dr. Cha...
Novel Therapies to Manage OFF Episodes in Patients with Parkinson’s Disease 25.11.2020 26:00
Host: Robert A. Hauser, MD, MBA, FAAN Guest: Stuart H. Isaacson, MD Please note: This activity is no longer available for continuing education credit. This Expert Exchange activity is designed to make clinicians aware of the potential for emerging pharmacotherapies in treating patients with Parkinson’s disease. You can access the Clinical Compendium for Novel Therapies to Manage OFF Episodes in Pa...
CMS Response to the COVID-19 Pandemic 10.11.2020 16:00
Host: Jennifer Caudle, DO Guest: Koryn Rubin With the widespread impacts of the COVID-19 pandemic, the Centers for Medicare and Medicaid Services is now offering flexibility for clinicians participating in the Merit-Based Incentive Payment System, MIPS. But what exactly does that flexibility entail? Dr. Jennifer Caudle is joined by Koryn Rubin to discuss how this impacts healthcare professionals....
CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy 05.10.2020 5:30
Host: Mikhail Kosiborod, MD Despite evidence and guideline recommendations, renin-angiotensin-aldosterone system inhibitor (RAASi) therapy tends to be used suboptimally among patients with heart failure (HF), particularly in patients with chronic kidney disease (CKD). What are the real-world factors that influence RAASi treatment decisions in patients with HF who have or are at risk for hyperkalem...
Virtual IBD Clinic: Disease Management and Surgery 04.06.2020 29:00
Guest: David P. Hudesman, MD Please note: This activity is no longer available for continuing education credit. It is estimated that only 20% to 30% of patients with Crohn’s disease (CD) have a non-progressive or indolent course. While most patients with CD present with non-penetrating or non-stricturing disease, 50% of patients develop intestinal complications within 20 years of diagnosis. In thi...
Options for an Infant with Atopic Dermatitis 28.02.2020 13:00
Guest: Peter A. Lio, MD Guest: Mark Boguniewicz, MD Guest: Eric Simpson, MD, MCR Please note: This activity is no longer available for continuing education credit. Infants have the highest incidence of atopic dermatitis in the US but the fewest treatment options. This is a case a doctor submitted about a baby who is refractory to multiple oral and topical treatments. A multidisciplinary panel disc...
Using a Biologic in a Patient with Atopic Dermatitis and HSV Keratitis 28.02.2020 11:00
Guest: Peter A. Lio, MD Guest: Mark Boguniewicz, MD Guest: Eric Simpson, MD, MCR Please note: This activity is no longer available for continuing education credit. A multidisiplinary panel is presented with a highly allergic, extremely refractory patient with atopic dermatitis. Her dermatologist wants to take the next step and start her on a biologic, but she's worried about the patient's occular...
Combining Biologics in a Young Patient with Atopic Dermatitis 28.02.2020 6:30
Guest: Peter A. Lio, MD Guest: Mark Boguniewicz, MD Guest: Eric Simpson, MD, MCR Please note: This activity is no longer available for continuing education credit. Tune in as a multidisciplinary panel discusses a clinician's question about the appropriateness of combining two biologics in a very young child with several atopic diseases.
Sniffing Out the Problem: A Dive into Management for Chronic Rhinosinusitis with Nasal Polyps 26.12.2019 16:30
Host: Joseph K. Han, MD Please note: This activity is no longer available for continuing education credit. Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with significant morbidity and negatively impacts quality of life. The good news is that biologic therapies targeting type 2 inflammatory pathways provide additional treatment options for CRSwNP. However, clinicians not only need...
Clinical Exchanges®: Optimizing Management of Nontuberculous Mycobacteria Lung Disease 26.12.2019 24:30
Host: Anne O'Donnell, MD Guest: Robert "Brinkley" Sewell Please note: This activity is no longer available for continuing education credit. The successful management of nontuberculous mycobacteria lung disease (NTM-LD) remains challenging owing to the need for long-term treatment, the ongoing risks of adverse drug reactions, and the potential for nonadherence. These factors undersco...
Clinical Reflections®: Reflecting on Missed Opportunities in Nontuberculous Mycobacteria Lung Disease 26.12.2019 31:30
Host: Anne O'Donnell, MD Guest: Patrick Flume, MD Please note: This activity is no longer available for continuing education credit. Nontuberculous mycobacteria lung disease (NTM-LD) is a relatively uncommon condition, although its prevalence is rising. In this interactive CME activity, Drs. Anne O’Donnell and Patrick Flume review two patient cases to demonstrate how clinicians can maintain a...
Advances in the Management of Moderate-to-Severe Atopic Dermatitis 17.10.2019 27:30
Host: Peter A. Lio, MD Guest: Eric Simpson, MD, MCR Guest: Mark Boguniewicz, MD Please note: This activity is no longer available for continuing education credit. “I begged my doctor for something else – there had to be something else,” Pam. For over 50 years, Pam suffered with uncontrolled moderate-to-severe atopic dermatitis (AD). She experienced the evolution of treatment strategies over the co...
Interstitial Pneumonia with Autoimmune Features (IPAF): A Research Classification 30.09.2019 16:00
Host: Shira Johnson, MD Guest: Amy L. Olson, MD, MSPH Guest: Jeffrey Swigris, DO, MS Guest: Katherine Rosen, RN, MSN, ANP-C Please note: This activity is no longer available for continuing education credit. This discussion highlights the diagnosis of and treatment approach for interstitial pneumonia with autoimmune features (IPAF).
How to Identify & Manage Patients with Progressive-Fibrosing ILD 30.09.2019 11:00
Host: Shira Johnson, MD Guest: Amy L. Olson, MD, MSPH Guest: Jeffrey Swigris, DO, MS Guest: Katherine Rosen, RN, MSN, ANP-C Please note: This activity is no longer available for continuing education credit. This discussion highlights the challenges associated with progressive-fibrosing ILD diagnosis, explains management differences for connective tissue disease-associated ILD, and reviews therapeu...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.